Literature DB >> 23678967

Membrane association and destabilization by Aggregatibacter actinomycetemcomitans leukotoxin requires changes in secondary structures.

M J Walters1, A C Brown, T C Edrington, S Baranwal, Y Du, E T Lally, K Boesze-Battaglia.   

Abstract

Aggregatibacter actinomycetemcomitans is a common inhabitant of the upper aerodigestive tract of humans and non-human primates and is associated with disseminated infections, including lung and brain abscesses, pediatric infective endocarditis, and localized aggressive periodontitis. Aggregatibacter actinomycetemcomitans secretes a repeats-in-toxin protein, leukotoxin, which exclusively kills lymphocyte function-associated antigen-1-bearing cells. The toxin's pathological mechanism is not fully understood; however, experimental evidence indicates that it involves the association with and subsequent destabilization of the target cell's plasma membrane. We have long hypothesized that leukotoxin secondary structure is strongly correlated with membrane association and destabilization. In this study, we tested this hypothesis by analysing lipid-induced changes in leukotoxin conformation. Upon incubation of leukotoxin with lipids that favor leukotoxin-membrane association, we observed an increase in leukotoxin α-helical content that was not observed with lipids that favor membrane destabilization. The change in leukotoxin conformation after incubation with these lipids suggests that membrane binding and membrane destabilization have distinct secondary structural requirements, suggesting that they are independent events. These studies provide insight into the mechanism of cell damage that leads to disease progression by A. actinomycetemcomitans. 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

Entities:  

Keywords:  conformation; intrinsic disorder; lipid membrane; unordered; α-helix

Mesh:

Substances:

Year:  2013        PMID: 23678967      PMCID: PMC3749273          DOI: 10.1111/omi.12028

Source DB:  PubMed          Journal:  Mol Oral Microbiol        ISSN: 2041-1006            Impact factor:   3.563


  50 in total

1.  Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans.

Authors:  Scott C Kachlany; Daniel H Fine; David H Figurski
Journal:  Protein Expr Purif       Date:  2002-08       Impact factor: 1.650

2.  Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization.

Authors:  Angela C Brown; Kathleen Boesze-Battaglia; Yurong Du; Frank P Stefano; Irene R Kieba; Raquel F Epand; Lazaros Kakalis; Philip L Yeagle; Richard M Epand; Edward T Lally
Journal:  Cell Microbiol       Date:  2012-03-28       Impact factor: 3.715

3.  Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes.

Authors:  F Olson; C A Hunt; F C Szoka; W J Vail; D Papahadjopoulos
Journal:  Biochim Biophys Acta       Date:  1979-10-19

4.  Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes.

Authors:  G Menestrina; N Mackman; I B Holland; S Bhakdi
Journal:  Biochim Biophys Acta       Date:  1987-11-27

5.  Analysis of protein circular dichroism spectra for secondary structure using a simple matrix multiplication.

Authors:  L A Compton; W C Johnson
Journal:  Anal Biochem       Date:  1986-05-15       Impact factor: 3.365

6.  Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans.

Authors:  J M DiRienzo; C C Tsai; B J Shenker; N S Taichman; E T Lally
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

7.  Periodontopathic bacteria in young healthy subjects of different ethnic backgrounds in Los Angeles.

Authors:  Garo Sirinian; Tota Shimizu; Catherine Sugar; Jørgen Slots; Casey Chen
Journal:  J Periodontol       Date:  2002-03       Impact factor: 6.993

8.  Membrane restructuring by Bordetella pertussis adenylate cyclase toxin, a member of the RTX toxin family.

Authors:  César Martín; M-Asunción Requero; Jiri Masin; Ivo Konopasek; Félix M Goñi; Peter Sebo; Helena Ostolaza
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

Review 9.  Actinobacillus actinomycetemcomitans endocarditis.

Authors:  L Paturel; J P Casalta; G Habib; M Nezri; D Raoult
Journal:  Clin Microbiol Infect       Date:  2004-02       Impact factor: 8.067

10.  Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.

Authors:  C C Tsai; B J Shenker; J M DiRienzo; D Malamud; N S Taichman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more
  11 in total

1.  Bacterial RTX toxins allow acute ATP release from human erythrocytes directly through the toxin pore.

Authors:  Marianne Skals; Randi G Bjaelde; Jesper Reinholdt; Knud Poulsen; Brian S Vad; Daniel E Otzen; Jens Leipziger; Helle A Praetorius
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

2.  Pore forming activity of the potent RTX-toxin produced by pediatric pathogen Kingella kingae: Characterization and comparison to other RTX-family members.

Authors:  Iván Bárcena-Uribarri; Roland Benz; Mathias Winterhalter; Eleonora Zakharian; Nataliya Balashova
Journal:  Biochim Biophys Acta       Date:  2015-04-07

3.  Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.

Authors:  A C Brown; E Koufos; N V Balashova; K Boesze-Battaglia; E T Lally
Journal:  Mol Oral Microbiol       Date:  2015-10-12       Impact factor: 3.563

4.  Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.

Authors:  Angela C Brown; Nataliya V Balashova; Richard M Epand; Raquel F Epand; Alvina Bragin; Scott C Kachlany; Michael J Walters; Yurong Du; Kathleen Boesze-Battaglia; Edward T Lally
Journal:  J Biol Chem       Date:  2013-06-21       Impact factor: 5.157

5.  Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.

Authors:  Nataliya Balashova; Alexander Giannakakis; Angela C Brown; Evan Koufos; Roland Benz; Tsutomu Arakawa; Hsin-Yao Tang; Edward T Lally
Journal:  Gene       Date:  2018-06-04       Impact factor: 3.688

Review 6.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

7.  Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.

Authors:  Steen K Fagerberg; Martin R Jakobsen; Marianne Skals; Helle A Praetorius
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

8.  Inhibition of Bacterial Toxin Activity by the Nuclear Stain, DRAQ5™.

Authors:  Joshua N Webb; Evan Koufos; Angela C Brown
Journal:  J Membr Biol       Date:  2016-04-02       Impact factor: 1.843

9.  Aggregatibacter actinomycetemcomitans Leukotoxin Is Delivered to Host Cells in an LFA-1-Indepdendent Manner When Associated with Outer Membrane Vesicles.

Authors:  Justin B Nice; Nataliya V Balashova; Scott C Kachlany; Evan Koufos; Eric Krueger; Edward T Lally; Angela C Brown
Journal:  Toxins (Basel)       Date:  2018-10-13       Impact factor: 4.546

10.  Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans.

Authors:  Angela C Brown; Kathleen Boesze-Battaglia; Nataliya V Balashova; Nestor Mas Gómez; Kaye Speicher; Hsin-Yao Tang; Margaret E Duszyk; Edward T Lally
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.